Filing Details

Accession Number:
0001209191-18-042581
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-13 19:22:24
Reporting Period:
2018-07-12
Accepted Time:
2018-07-13 19:22:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655234 Keith Edward Russell 12544 High Bluff Drive
Suite 200
San Diego CA 92130
S.v.p., N.a. Commercial Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-12 10,000 $18.32 18,887 No 4 M Direct
Common Stock Disposition 2018-07-12 10,000 $68.09 8,887 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2018-07-12 10,000 $0.00 10,000 $18.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,211 2017-10-12 2025-10-12 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $68.093769 per share, with a range of $67.52 to $69.02. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.